P46351 7th Annual Cell Line Development and Engineering Asia 2018
Download Brochure Request

Register your interest


Register your interest


7th Annual Cell Line Development and Engineering Asia 2018

16 – 17 May 2018, Hilton Shanghai Hongqiao Hotel, China

Download Brochure



IBC’s 7th Annual Cell Line Development and Engineering Asia is part of Biopharma Development and Production (BDP) Week 2018. The industry’s foremost event showcases the views of top technical professionals in both research and industry best practices in engineering and optimizing cell lines for low cost, high quality, high productivity and scalability. Benchmark R&D, regulatory and commercial considerations between China and the rest of the world, and network across multiple events to make the most of your investment.

2018 Attendees List

View list >>

Key highlights

  • 300+ Companies, 70+ speakers, 60+ Sessions
  • Unparalleled learning and targeted networking across three 3 co-located events
  • Innovative approaches in early cell line development
  • Revolution of Gene-editing tools in Cell Line Engineering
  • Optimizing Technologies for Antibody therapy
  • Scale-up and Process Development
  • Assuring High Yield and High Quality
  • Preview latest equipment and technologies and hear from top vendors on how they are partnering with your peers
  • Innovation in technologies and manufacturing process

Choose your language

Part of

Biopharma Development & Production >>

Co-Located Events

Biosimilars Asia >>
Cell Line Development and Engineering >>
Biomanufacturing >>


Partnership and Profile Building Opportunities are Now Available!
Contact us today to find out how you can position your company as a market leader at this event, and to explore the range of branding and marketing opportunities available.

View Sponsors and Exhibitors profile >>

VIP Programme

Become a VIP!
IBC Asia’s VIP Programme is an invitation only based network of the absolute top decision makers across specific industries. Our VIPs get an exclusively designed and tailored programme that enables them to network, indulge and enjoy, whilst experiencing a premium service for the duration of this event.

Dedicated to helping you find the most effective way of engaging with professionals and industry solution providers at our event, and scheduled alongside the main event line-up, it gives you an opportunity to glean benefits from the conference as well, and ensures that you get the most of your time on site with us.

Benefits of becoming a VIP:

  • 1-2-1 Meeting Service (Pre-scheduling meetings with your peers, speakers and other participants you may want to meet)
  • Closed Door Think Tank (An invitation-only forum headlined by an exclusive keynote address)
  • The VIP Lounge
  • Opening Ceremony (Access priority seats and be the first to engage with key speakers and other top decision makers)
  • Your Interview, Promoted Exclusively

A personalized VIP agenda will be sent to you via email upon receiving the confirmation of your registration.

To find out more, please contact:
Angeline Tan, VIP Relations Manager
Email: Angeline.Tan.SG1@ibcasia.com.sg
Phone: +65 6508 2874

Download VIP Programme brochure »


Dr. Ming Wang

President and Chief Executive Officer, Phanes Biopharmaceuticals, China

Xiao Zhi Hua

Chief Executive Officer, OPM Biosciences, China

Xu Wei

Vice President, Manufacturing, Innovent Biologics, China

Jerry Yang

SVP, Process & Product Development, Hangzhou JUST Biotherapeutics Co., Ltd., China

Dr Jun Liu

Vice President, TOT Biopharma, China

Yanshan Huang

Chief Executive Officer, DOER Biologics, China

Andrew Huntley

Senior Managing Director, BDA Partners, UK

Sunny Zhou

Professor, Department of Chemistry and Chemical Biology Faculty Fellow, Barnett Institute of Chemical and Biological Analysis Northeastern University, Boston, Massachusetts

Jerry Clifford

Chief Operating Officer, Valitacell, Ireland

Keith Breinlinger

Chief Technology Officer, Berkeley Lights, USA

George Hutchinson

Head of Global Distribution, Solentim, UK

Eric Chang

Head of Cell Line Development, JHL Biotech, Taiwan

Dr. John Yan

Applications Scientist, ProZyme

Fai Poon Hung

President, Quacell Biotech, China

Julie Wei

Director, JUST Biotherapeutics, China

Sam Zhang

Senior Principal Scientist/Group Leader, Cell Line Development, Bioprocess R&D, Pfizer Inc, USA

Prof. David James

University of Sheffield

Ng Say Kong

Staff Scientist, Animal Cell Technology 2, Bioprocessing Technology Institute, A*STAR

Zhiwei Pan

Senior Director of Process Development, Livzon Mabpharm, China

Shaoqing Yang

Vice President, Zhejiang Doer Biologics Co.

Wang Tong Ying

Chief Technical Officer, Hangzhou Jiuyuan Gene Engineering, China

Dong Huifang

Director of Cell Line Development, WuXi Biologics, China

Sai Ling Liu

Product Development Expert, Surfer Biotech, China

Dr Jun Yuan

R&D Director, Quacell Biotechnology Co. Ltd, China

Zhou Hui

Chief Executive Officer, Glycogene Biotherapeutics, China

Yun Kang

Vice President of Manufacturing, Generon Beijing, China

Dr. Alvin Luk

Senior Vice President and Chief Medical Officer, Shanghai Henlius Biotech, Inc., China

Zheru Zhang

President, I-Mab Biopharma, China

when & where

16 - 17 May 2018

Hilton Shanghai Hongqiao
No. 1116 Hong Song East Rd, Shanghai, 201103, China
Tel: +86-21-3323 6666


Still have a question?

Speaking Opportunities
Win Min
+65-6508 2873

Sponsorship Opportunities
Yvonne Leong
+65 6508 2489


Media & Association Partnership Opportunities
June Tan
+65 6508 2465


IBC Asia is Singapore's leading event organiser. We conceive, develop and promote our own B2B industry conferences and corporate training courses, and offer tailored managed event solutions.

Find out more